Novartis AG (NVS)
138.72
-0.48
(-0.34%)
USD |
NYSE |
Dec 30, 16:00
138.50
-0.22
(-0.16%)
Pre-Market: 20:00
Novartis Market Cap: 266.17B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Roche Holding AG | 329.17B |
| Amgen, Inc. | 176.99B |
| AstraZeneca PLC | 286.83B |
| Regeneron Pharmaceuticals, Inc. | 81.34B |
| Avidity Biosciences, Inc. | 10.87B |
Market Cap Related Metrics
| PE Ratio | 18.92 |
| PS Ratio | 5.021 |
| Price to Book Value | 6.004 |
| Price to Free Cash Flow | 15.94 |
| Price | 138.72 |
| Earnings Yield | 5.29% |
| Operating PE Ratio | 15.81 |
| Normalized PE Ratio | 17.97 |